(MGNX)
0.00
0.00 (0.00%)
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
0.00
0.00 (0.00%)
MacroGenics, Inc., klinik davrdagi biofarmatsevtika kompaniyasi, Qo'shma Shtatlarda saratonni davolash uchun antitelalarga asoslangan terapevtik vositalarni kashf qiladi, ishlab chiqadi, ishlab chiqaradi va tijoratlashtiradi. Kompaniyaning mahsulot quvuri orasida lorigerlimab, mCRPCni davolash uchun PD-1 va CTLA-4 nazorat nuqtasi inhibitörlerine yo'naltirilgan bispesifik DART molekulasi va 2-bosqichli klinik sinovlarda bo'lgan, shuningdek, platina-rezistent tuxumdon saratoni va 1-bosqichli klinik sinovlarni yakunlagan yorug' hujayrali ginekologik saratonni davolash uchun dosetaksel mavjud; B7-H3 ni nishonga oladigan va yangi topoisomerase I inhibitori (TOP1i) asosidagi linker-yukni yetkazib beradigan ADC MGC026; qattiq o'smalarni davolash uchun ADAM9 ni nishonga oladigan va yangi TOP1i asosidagi linker-yukni yetkazib beradigan antitelali-dorivor konjugatlar (ADC) MGC028, ular 1-bosqichli klinik sinovlarda; bir nechta qattiq o'smalarda ifodalangan noma'lum antigenni nishonga oladigan va preklinik sinovlarda bo'lgan ADC molekulasi MGC030. Kompaniya T-hujayralarni faollashtiruvchi dasturlarni ham ishlab chiqmoqda. Kompaniya TerSera Therapeutics LLC; Incyte Corporation; va Gilead Sciences, Inc. bilan hamkorlik qiladi. MacroGenics, Inc. 2000 yilda tashkil etilgan va uning shtab-kvartirasi Merilend shtatining Rokvill shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Ezio Bonvini M.D. | Senior VP of Research & Chief Scientific Officer |
| Dr. Frank George Perabo FEBU, M.D., Ph.D. | Vice President & Interim Head of Clinical Development |
| Dr. Thomas M. Spitznagel Ph.D. | Senior Vice President of Technical Operations |
| Mr. Eric Blasius Risser | CEO, President & Director |
| Mr. Harish Krishnaswamy | Senior Vice President of Business Development & Portfolio Planning |
| Mr. James Karrels | Senior VP, CFO & Corporate Secretary |
| Mr. Jeffrey Stuart Peters J.D. | Senior VP, General Counsel & Corporate Compliance Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-03-09 | 10-K | mgnx-20251231.htm |
| 2026-03-02 | 8-K | mgnx-20260302.htm |
| 2025-11-20 | 8-K | mgnx-20251114.htm |
| 2025-11-12 | 8-K | mgnx-20251112.htm |
| 2025-08-14 | 8-K | mgnx-20250814.htm |
| 2025-08-13 | 8-K | mgnx-20250813.htm |
| 2025-06-10 | 8-K | mgnx-20250609.htm |
| 2025-05-22 | 8-K | mgnx-20250521.htm |
| 2025-05-13 | 8-K | mgnx-20250513.htm |
| 2025-04-11 | DEF 14A | mgnx-20250411.htm |
| Mr. Steve Harig | Senior Vice President of Human Resources |
| Ms. Beth Smith | VP, Controller & Treasurer |